
Celon Pharma S.A.
CLN | WAR
Overview
Corporate Details
- ISIN(s):
- PLCLNPH00015 (+3 more)
- LEI:
- 259400Q0ERJT0NC5DT24
- Country:
- Poland
- Address:
- KAZUŃ NOWY MARYMONCKA 15, 05-152 KAZUŃ NOWY
- Website:
- https://celonpharma.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life. One huge advantage of Celon Pharma S.A. is its strong research and development facilities which allow us to create whole new classes of effective drugs. The research and development department in Celon Pharma S.A.employs over 160 scientists, of which one in four have PhD titles in molecular biology, pharmacy or chemistry. We invest in the development of innovative pharmaceutical products which have the potential to treat cancers, neurological diseases, diabetes and other metabolic disorders. We have obtained financial resources for research into new drugs from the sale of generic drugs, as well as from the EU funds obtained under the Innovative Economy programme.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-04 15:16 |
Capital/Financing Update
Uzgodnienie z Europejskim Bankiem Odbudowy i Rozwoju głównych warunków udzielen…
|
Polish | 1.5 KB | |
2025-07-16 21:15 |
Major Shareholding Notification
zal01_TCM_Celon_Notification_Form.pdf
|
English | 89.7 KB | |
2025-07-16 21:15 |
Major Shareholding Notification
Otrzymanie zawiadomienia o przekroczeniu progu 5% udziału w ogólnej liczbie gło…
|
Polish | 1.1 KB | |
2025-06-26 21:39 |
Post-Annual General Meeting Information
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
|
Polish | 888 bytes | |
2025-06-26 21:36 |
Post-Annual General Meeting Information
Uchwały podjęte przez ZWZ
|
Polish | 221.8 KB | |
2025-06-26 21:36 |
Post-Annual General Meeting Information
Uchwały podjęte przez Zwyczajne Walne Zgromadzenie Celon Pharma S.A. w dniu 26 …
|
Polish | 559 bytes | |
2025-06-03 09:16 |
Regulatory News Service
Przekazanie informacji o wprowadzeniu produktu leczniczego TIKOZEK do regulator…
|
Polish | 1021 bytes | |
2025-05-30 17:57 |
Remuneration Information
zal05_Sprawozdanie_o_wynagrodzeniach_Czlonkow_Zarzadu_i_RN_Celon_Pharma_SA_za_2…
|
Polish | 274.1 KB | |
2025-05-30 17:57 |
Remuneration Information
zal04_Projekt_Polityka_Wynagrodzen_zalacznik_do_uchwaly_nr_17_ZWZ_Celon_Pharma_…
|
Polish | 149.4 KB | |
2025-05-30 17:57 |
Board/Management Information
zal03_Celon_Pharma_Sprawozdanie_Rady_Nadzorczej_za_2024.pdf
|
Polish | 672.4 KB | |
2025-05-30 17:57 |
Pre-Annual General Meeting Information
zal01_Celon_Pharma_Projekty_uchwal_na_ZWZ_26_06_2025.pdf
|
Polish | 258.6 KB | |
2025-05-30 17:57 |
Pre-Annual General Meeting Information
zal02_Celon_Pharma_Ogloszenie_o_zwolaniu_ZWZ_26_06_2025.pdf
|
Polish | 243.1 KB | |
2025-05-30 17:57 |
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Celon Pharma S.A. na dzi…
|
Polish | 2.7 KB | |
2025-05-21 17:05 |
Quarterly Report
Raport za 1 kwartał 2025
|
Polish | 2.0 MB | |
2025-05-06 15:48 |
Legal Proceedings Report
Podpisanie umowy o objęcie wsparciem projektu Celon Pharma S.A. w ramach Krajow…
|
Polish | 2.9 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Vimian Group AB | Sweden | VIMIAN | |
![]() |
Virbac | France | FR000 | |
|
Vistin Pharma | Norway | VISTN | |
![]() |
Vivesto | Sweden | VIVE | |
![]() |
WAKAMOTO PHARMACEUTICAL CO.,LTD. | Japan | 4512 | |
![]() |
Xlife Sciences AG | Switzerland | XLS | |
![]() |
Xspray Pharma | Sweden | XSPRAY | |
![]() |
Y.B Urban Renewal - Residential Development LTD | Israel | CSURE-M | |
![]() |
YUKI GOSEI KOGYO CO.,LTD. | Japan | 4531 | |
![]() |
Zentiva 2 | Slovakia | SKF |